CompoAtlas

Vitarthro

Food supplement declared in France, declaration No 2019-2-987

Vitarthro is a food supplement declared in France. Status: retiré du marché le 1 October 2026. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
not provided
Food business operator placing the product on the market
GAUTIER
Status
Retiré du marché le 1 October 2026
Form
Gélule
Daily dose
2 gélules par jour
Directions for use
2 gélules par jour, à avaler avec un grand verre d'eau
Objectives stated by the manufacturer (these are not authorised claims)
Os, Articulations

Declaration 293925, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Boswellia serrata Roxb. ex Colebr.RésineExtrait sec aqueux200 mg

Other active ingredients

NamePer day
Chlorhydrate de glucosaminenot declared
Sulfate de chondroïtinenot declared

Other ingredients

gélatine

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Tenir hors de portée des jeunes enfants. Ne pas dépasser la dose conseillée. A consommer dans le cadre d'une alimentation variée et équilibrée et d'un mode de vie sain. Contient des crustacés et produits issus des crustacés, du poisson et produits à base de poissons ainsi que des mollusques et produits à base de mollusques.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Enter to analyse, Shift+Enter for a new line